Accurate Education - Magnesium for Chronic Pain: A Patient Guide

Nutraceuticals:

Magnesium for Chronic Pain: A Patient Guide

Magnesium acts as a natural, low-cost option for managing chronic pain, particularly for conditions involving nervous system pain, muscle aches, and spasms. It works as an NMDA receptor blocker to inhibit pain signals and reduce central sensitization. While often used as an adjunct therapy, it may be effective for neuropathic pain (including chemotherapy-induced peripheral neuropathy, postherpetic neuralgia), and migraines., migraine, and muscle cramps.

See:

Nutraceutical Patient Guides:

Key to Links:

Grey text – handout
Red text – another page on this website
Blue text – Journal publication

Definitions and Terms Related to Pain

Magnesium for Chronic Pain: A Patient Guide

1. OVERVIEW

Magnesium is an essential mineral and the second most abundant intracellular divalent cation in the body, serving as a cofactor for over 300 enzymatic reactions including energy production, protein synthesis, and nerve transmission.[1][2] Approximately 60% of body magnesium is stored in bone, with less than 1-2% in blood.[3]

What makes magnesium valuable for chronic pain:

Physiological antagonist of the N-methyl-D-aspartate (NMDA) receptor, preventing central sensitization and attenuating pain hypersensitivity[1][4][5]
Blocks calcium channels and modulates potassium channels involved in pain transmission[4]
Reduces inflammatory markers including C-reactive protein (CRP), IL-6, and TNF-α[6][1]
Inhibits NF-κB signaling, reducing inflammatory gene expression[1][4]
Supports mitochondrial function and reduces oxidative stress[1][7]
May restore normal NMDA receptor phosphorylation in the spinal cord[5][8]

How Magnesium Compares to Conventional Medications:

Unlike NSAIDs, magnesium does not cause gastrointestinal ulceration or cardiovascular risks with long-term use. However, clinical evidence for chronic pain conditions remains modest, with systematic reviews describing efficacy as “equivocal” across most pain syndromes.[9][10] Magnesium has the strongest evidence for migraine prophylaxis (Grade C – possibly effective) and shows promising signals for fibromyalgia and neuropathic pain.[1][6] The onset of benefit is gradual (weeks to months), and optimal dosing for specific pain conditions has not been definitively established.[10]

—

2. DIETARY SOURCES

Magnesium is obtained through dietary intake, with 30-40% of consumed magnesium absorbed in the intestine.[3] Most absorption occurs in the small intestine through passive paracellular transport, with fine-tuning in the large intestine via TRPM6/TRPM7 channels.[3]

High Magnesium Food Sources:

Nuts (almonds, cashews, peanuts): 50-80 mg per ounce
Seeds (pumpkin, chia): 150 mg per ounce
Leafy green vegetables (spinach, Swiss chard): 75-150 mg per cup cooked
Legumes (black beans, edamame): 60-120 mg per cup
Whole grains (quinoa, brown rice): 80-120 mg per cup cooked
Dark chocolate (70-85% cacao): 65 mg per ounce
Avocado: 58 mg per avocado
White potatoes (with skin): 50 mg per medium potato[2]

Recommended Daily Intake:

Men: 400-420 mg/day
Women: 310-320 mg/day[2]

Important Bioavailability Notes:

Dietary magnesium bioavailability ranges from 30-50% depending on food source and individual factors[3]
Factors that enhance absorption: adequate vitamin D, protein intake, and healthy gut microbiota[11]
Factors that inhibit absorption: high phytate intake (unprocessed grains), high fiber, high phosphorus, and certain medications[11]
Western diets often provide insufficient magnesium due to food processing and consumption of refined foods[7]
Hypomagnesemia is present in 3-10% of the general population, with higher prevalence in hospitalized patients and those with type 2 diabetes[3]

—

3. INDICATIONS FOR NUTRACEUTICAL SUPPLEMENTATION

Pain Conditions with Clinical Evidence:

Migraine Prevention – MODERATE Clinical Evidence (Grade C)

Systematic review of 5 RCTs showed Grade C (possibly effective) evidence for migraine prophylaxis[1]
Meta-analysis demonstrated mean reduction of 2.6 migraine headaches per month after 12 weeks of treatment[12]
Doses of 400-600 mg daily (citrate or oxide formulations) used in clinical trials[12]
VA/DoD guidelines recommend consideration of oral magnesium for migraine prevention[12]

Fibromyalgia – LOW-MODERATE Clinical Evidence

RCT showed magnesium 100 mg/day significantly reduced pain severity (p=0.029) and mild/moderate stress in fibromyalgia patients[6]
Magnesium deficiency is commonly observed in fibromyalgia patients[1]
Additional clinical trials needed to establish optimal dosing[10]

Neuropathic Pain – LOW-MODERATE Clinical Evidence

Beneficial effects reported in diabetic neuropathy, postherpetic neuralgia, and chemotherapy-induced peripheral neuropathy[1]
Preclinical evidence shows magnesium attenuates allodynia and hyperalgesia via NMDA receptor blockade[5][8]
Serum magnesium inversely associated with diabetic polyneuropathy severity[13]

Dysmenorrhea – LOW-MODERATE Clinical Evidence

Magnesium treatment reportedly alleviates menstrual pain[1]
May work through smooth muscle relaxation and anti-inflammatory effects

Acute Migraine – LOW Clinical Evidence

Intravenous magnesium may provide relief for acute migraine attacks[1][14]
Most evidence from emergency department settings

Muscle Cramps – LOW Clinical Evidence (Conflicting)

Cochrane review found magnesium unlikely to provide clinically meaningful cramp prophylaxis in older adults[15]
Evidence conflicting for pregnancy-associated leg cramps[15]
Despite widespread use, RCT evidence does not support efficacy for nocturnal leg cramps[16]

—

4. MAGNESIUM’S IMPACT ON PAIN CONDITIONS

Magnesium addresses underlying pathophysiology of chronic pain through multiple mechanisms:

NMDA Receptor Antagonism:

Voltage-dependent blockade of NMDA receptor ion channels[1][4][5]
Prevents glutamate-mediated excitotoxicity and neuronal hyperexcitability[4]
Reduces wind-up phenomenon and temporal summation of pain[4]

Anti-Inflammatory Actions:

Reduces C-reactive protein (CRP) levels[6]
Decreases pro-inflammatory cytokines (IL-1, IL-6, TNF-α)[1][4]
Inhibits NF-κB nuclear translocation[1][4]
Reduces nitric oxide overproduction in inflammatory states[6]

Neuromuscular Effects:

Regulates calcium influx into cells, affecting muscle contraction[17]
Modulates neuromuscular transmission[17]
Supports normal nerve conduction[3]

Vascular Effects (Relevant to Migraine):

Promotes vasodilation through calcium channel effects[14]
May prevent cortical spreading depression implicated in migraine aura[14]
Reduces platelet aggregation[14]

—

5. MAGNESIUM’S IMPACT ON PAIN PROCESSING

Pain processing refers to how pain signals are processed from the initial damaged tissue source of pain through the nerves and spinal cord to the brain and then down the spinal cord again. Magnesium offers potential benefit for reducing the severity of the pain experience by acting at various levels of pain processing.

Level 1: Peripheral Pain Receptor (Nociception Transduction)

Modulates calcium channels at peripheral nerve terminals[4]
Reduces peripheral inflammatory mediators that sensitize nociceptors[12]
Note: Paradoxically, local injection of magnesium can activate peripheral TRPA1, TRPV1, and TRPV4 receptors causing local pain[4]

Level 2: Primary Afferent Transmission to Spinal Cord

Protects dorsal root ganglion neurons from inflammatory and metabolic damage[13]
Prevents methylglyoxal-induced neurotoxicity in diabetic neuropathy[13]
Supports normal nerve conduction velocity[5]

Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)

Blocks NMDA receptors in spinal cord dorsal horn, the primary site of antinociceptive action[1][4][5]
Prevents phosphorylation of NMDA receptor NR1 subunit[5][8]
Inhibits spinal cord microglial and astrocytic activation[12]
Reduces spinal cord inflammatory cytokine production[12]
Attenuates long-term potentiation at C-fiber synapses[12]

Level 4: Ascending Spinal Pathways and Supraspinal Processing

Provides neuroprotection through antioxidant mechanisms[1]
Reduces neuroinflammation in ascending pain pathways[1]

Level 5: Brain Cortical Processing and Pain Perception
May prevent cortical spreading depression (relevant to migraine)[14]
Supports normal neurotransmitter function[3]
Magnesium acetyl taurate shows preferential brain penetration and anxiolytic effects[18]

Level 6: Descending Pain Modulation

Supports serotonergic and noradrenergic descending inhibitory pathways[1]
Reduces central inflammatory processes that impair descending inhibition[1]

—

6. BENEFITS FOR PAIN SENSITIZATION

Peripheral Sensitization: MODERATE Preclinical/LOW Clinical Evidence

Reduces inflammatory mediators at sites of tissue injury[6][1]
Decreases prostaglandin and cytokine-mediated sensitization of nociceptors[1]
Protects peripheral nerves from metabolic damage (e.g., methylglyoxal in diabetes)[13]

Central Sensitization: MODERATE Preclinical/LOW-MODERATE Clinical Evidence

Primary mechanism of magnesium’s analgesic effect is NMDA receptor blockade in spinal cord[1][4][5]
Prevents phosphorylation of spinal NMDA receptor NR1 subunit[5][8]
Attenuates wind-up and temporal summation[4]
Reduces spinal cord glial activation[12]
Blocks development of long-term potentiation at pain synapses[12]

—

7. MAGNESIUM’S IMPACT ON THE 4 DRIVING FORCES OF CHRONIC PAIN

1. Systemic Inflammation: MODERATE EFFECT

Meta-analysis shows significant reduction in C-reactive protein (CRP) with supplementation[6]
Reduces pro-inflammatory cytokines (IL-1, IL-6, TNF-α)[1][4] Inhibits NF-κB signaling pathway[1][4]
Magnesium deficiency associated with chronic low-grade inflammation[7]

2. Neuroinflammation: MODERATE EFFECT

Reduces microglial and astrocyte activation in spinal cord[12]
Decreases neuroinflammatory cytokine production[1]
Prevents TRPM7-mediated inflammatory signaling[1]
Protects against neuronal oxidative damage[1]

3. Oxidative Stress: MODERATE EFFECT

Supports mitochondrial function and ATP production[1][7]
Increases glutathione (GSH) levels[4]
Reduces reactive oxygen species production[1][7]
Magnesium deficiency causes mitochondrial dysfunction and increased ROS[1][7]
Meta-analysis shows increased nitric oxide (NO) levels with supplementation[6]

4. Mitochondrial Dysfunction: MODERATE EFFECT

Essential cofactor for ATP synthesis and stabilization[1][7]
Supports mitochondrial membrane integrity[1]
Prevents mitochondrial-mediated oxidative stress[1]
Deficiency leads to impaired energy metabolism and increased triosephosphate accumulation[13]

—

8. DOSING, TIMING, DURATION AND ADMINISTRATION

Note: Optimal dosing for specific pain conditions has not been definitively established in clinical trials. The following are based on available evidence.

Recommended Dosing

Migraine prophylaxis

Dose: 400-600 mg/day
Formulation: Citrate, oxide, or dicitrate
Duration: 12+ weeks
Evidence Level: Moderate

Fibromyalgia

Dose: 100-300 mg/day
Formulation: Chloride or citrate
Duration: 4+ weeks
Evidence Level: Low-Moderate

Neuropathic pain

Dose: 300-500 mg/day
Formulation: Various
Duration: 8+ weeks
Evidence Level: Low

General supplementation

Dose: 200-400 mg/day
Formulation: Citrate, glycinate
Duration: Ongoing —
Evidence Level: Low

Key Dosing Points:

The Tolerable Upper Intake Level (UL) for supplemental magnesium is 350 mg/day, based on diarrhea as the limiting factor[19]
However, recent evidence suggests doses above 350 mg/day can be consumed without significant adverse events in most individuals[19]
Magnesium toxicity is rare at oral doses below 5,000 mg/day in patients with normal renal function[12]
Divide doses throughout the day to improve absorption and reduce GI side effects
Clinical trials for migraine used 400-600 mg elemental magnesium daily[1][12]

Timing:

Take with meals to reduce gastrointestinal side effects
Divided doses (2-3 times daily) may improve absorption and tolerability
Evening dosing may help with sleep quality

Duration of Onset:

Migraine prophylaxis: Allow 8-12 weeks to assess benefit[1]
Other chronic pain conditions: Allow minimum 4-8 weeks for initial assessment
Benefits are cumulative with consistent use

—

9. FORMULATION CONSIDERATIONS

Organic Salts (Higher Bioavailability):

Magnesium citrate: Good bioavailability, commonly used in clinical trials[3][20]
Magnesium glycinate (bisglycinate): Well-absorbed, less likely to cause diarrhea[3]
Magnesium malate: High area under the curve, sustained serum levels[18]‘
Magnesium taurate/acetyl taurate: Good brain penetration, may have anxiolytic effects[18]
Magnesium lactate: Good absorption, well-tolerated
Magnesium aspartate: Good bioavailability[3]
Magnesium threonate: May enhance brain magnesium levels, studied in chemotherapy-induced neuropathy (no clinical trials) [12]

Inorganic Salts (Lower Bioavailability):

Magnesium oxide: Low bioavailability (~4%), but high elemental magnesium content; commonly used despite poor absorption[3][20]
Magnesium chloride: Moderate bioavailability, comparable to citrate[20][21]
Magnesium carbonate: Low bioavailability

Specialized Formulations:

Microencapsulated magnesium: Sustained release, reduced GI side effects[12]
Marine-derived magnesium: Contains trace minerals, comparable bioavailability to chloride[20][21]

Quality Considerations:

Choose products with third-party testing (USP, NSF, ConsumerLab)
Note elemental magnesium content (varies by salt form)
Magnesium oxide contains ~60% elemental magnesium but has poor absorption
Magnesium citrate contains ~16% elemental magnesium but absorbs well
Store in cool, dry conditions

—

10. SYNERGIES WITH OTHER PAIN MEDICATIONS AND NUTRACEUTICALS

Nutraceuticals with Potential Synergy:

Vitamin D: Magnesium is required for vitamin D metabolism and activation; deficiency of either impairs the other[3]
Coenzyme Q10: Both support mitochondrial function; combined use studied in migraine[14]
Riboflavin (B2): Both recommended for migraine prophylaxis; complementary mechanisms[14]
Alpha-lipoic acid: Both reduce oxidative stress; studied in diabetic neuropathy
Omega-3 fatty acids: Complementary anti-inflammatory effects
Vitamin B6: May enhance magnesium cellular uptake

Conventional Medications:

Opioids: Magnesium may enhance opioid analgesia and reduce opioid requirements (primarily studied perioperatively)[5][22]
Gabapentinoids: No significant interaction; may have complementary mechanisms
Antidepressants (SNRIs, TCAs): No significant interaction; complementary for neuropathic pain
NSAIDs: Complementary mechanisms; magnesium may provide additional anti-inflammatory benefit
Triptans: No significant interaction; both used for migraine
Acetaminophen: No known interaction

—

11. DRUG INTERACTIONS

Clinically Significant Interactions:

Antibiotics (Tetracyclines, Fluoroquinolones) – SEPARATE DOSING

Magnesium chelates these antibiotics, reducing their absorption[23]
Separate administration by at least 2-4 hours

Bisphosphonates – SEPARATE DOSING

Magnesium reduces bisphosphonate absorption[23]
Take bisphosphonate at least 2 hours before magnesium

Neuromuscular Blocking Agents – USE CAUTION

Magnesium potentiates neuromuscular blockade[24]
Primarily relevant for parenteral magnesium in surgical settings

CNS Depressants – MONITOR

Magnesium may have additive CNS depressant effects with barbiturates, opioids, and anesthetics[24]
Primarily relevant for IV magnesium

Cardiac Glycosides (Digoxin) – USE CAUTION

Magnesium affects cardiac conduction[24]
Monitor in digitalized patients

Dihydropyridine Calcium Channel Blockers – MONITOR

Potential for exaggerated hypotensive response[25]
Monitor blood pressure

Drugs That Cause Magnesium Loss – MONITOR/SUPPLEMENT:

Proton pump inhibitors (PPIs): Cause hypomagnesemia in ~20% of long-term users[3][23]
Loop diuretics (furosemide): Increase renal magnesium excretion[3][23]
Thiazide diuretics: Increase renal magnesium excretion[3][23]
Aminoglycosides: Cause renal magnesium wasting[23]
Cisplatin and other chemotherapy: Cause significant magnesium depletion[3]
Calcineurin inhibitors (cyclosporine, tacrolimus): Reduce TRPM6/7 activity[3]
EGFR inhibitors (cetuximab): Cause hypomagnesemia in 20-40% of patients[3]

Generally Safe – No Known Significant Interactions:

Gabapentin, pregabalin
Most antidepressants (SSRIs, SNRIs)
Acetaminophen
Most antihypertensives (except as noted above)

—

12. SAFETY AND CONTRAINDICATIONS

Generally Favorable Safety Profile:

Oral magnesium supplementation is generally well-tolerated at recommended doses.[3][19] The primary limiting factor is gastrointestinal intolerance, particularly diarrhea.[3]

Common Side Effects (Dose-Dependent):

Diarrhea (most common, 11-37% in clinical trials)[15]
Nausea
Abdominal cramping
Bloating

Less Common Side Effects:

Hypotension (primarily with IV administration)
Flushing
Drowsiness

Signs of Hypermagnesemia (Rare with Oral Supplementation in Normal Renal Function):

Nausea, vomiting
Facial flushing
Hypotension
Muscle weakness
Lethargy
Cardiac conduction abnormalities (severe cases)[10]

Contraindications:

Severe renal impairment (GFR 30 mL/min) – magnesium accumulation risk[3][12]
Heart block (without pacemaker)
Myasthenia gravis (relative contraindication)

Use with Caution:

Moderate renal impairment – reduce dose and monitor levels[12]
Patients on medications that cause magnesium retention
Patients with hypotension
Pre-surgical patients receiving neuromuscular blocking agents

Pregnancy and Lactation:

Oral magnesium supplementation at recommended doses is generally considered safe during pregnancy[15]
IV magnesium sulfate is standard treatment for preeclampsia/eclampsia[24]
Adequate magnesium intake is important during pregnancy
Consult healthcare provider before supplementation

—

13. SPECIAL CONSIDERATIONS / TIPS

Serum magnesium is not a reliable marker: Less than 1% of body magnesium is in plasma; normal serum levels do not exclude intracellular deficiency.[3]
Start low and increase gradually: Begin with 100-200 mg/day and increase over 1-2 weeks to minimize GI side effects.
Choose the right formulation: Organic salts (citrate, glycinate, malate) have better bioavailability than oxide, though oxide provides more elemental magnesium per dose.[3][18]
Divide doses: Taking magnesium in 2-3 divided doses improves absorption and reduces diarrhea.
Take with food: Reduces GI side effects and may improve absorption.
Consider underlying deficiency: Patients on PPIs, diuretics, or with diabetes are at higher risk for magnesium deficiency and may benefit most from supplementation.[3]
Be patient: Benefits for chronic pain conditions typically require 4-12 weeks of consistent use.
Monitor for interactions: Separate magnesium from antibiotics and bisphosphonates by 2-4 hours.
Address vitamin D status: Magnesium is required for vitamin D activation; consider checking and optimizing both.[3]
For migraine: Higher doses (400-600 mg/day) are typically needed for prophylaxis; allow 12 weeks to assess benefit.[1][12]
For muscle cramps: Despite widespread use, evidence does not support efficacy for nocturnal leg cramps in older adults.[15][16]
Evidence limitations: While mechanistic evidence is strong, clinical trial evidence for most chronic pain conditions remains modest. Magnesium is best considered as an adjunctive therapy rather than primary treatment.

—

14. COSTS

Magnesium oxide (generic): $5-15 per month
Magnesium citrate: $10-20 per month
Magnesium glycinate: $15-30 per month
Magnesium malate: $15-25 per month
Magnesium threonate: $30-50 per month
Combination/specialty formulations: $20-40 per month

Magnesium supplements are available over-the-counter and do not require a prescription. Costs vary by brand, formulation, and elemental magnesium content. Generic magnesium oxide is the least expensive but has the poorest bioavailability. Better-absorbed forms (citrate, glycinate) cost moderately more but may provide better value due to improved absorption.

—

Summary: Magnesium is an essential mineral with strong mechanistic evidence for pain modulation through NMDA receptor antagonism, anti-inflammatory effects, and support of mitochondrial function. It has the some clinical evidence for migraine prophylaxis (Grade C – possibly effective) and shows promising signals for fibromyalgia and neuropathic pain.

However, systematic reviews describe overall efficacy for chronic pain as “equivocal,” and more definitive clinical trials are needed. The excellent safety profile at typical doses makes magnesium a reasonable adjunctive therapy to consider, particularly in patients with suspected deficiency or those taking medications that deplete magnesium. Benefits are gradual and modulatory rather than providing immediate pain relief. Always discuss any new supplement with your healthcare provider, especially if you have kidney disease or take medications that interact with magnesium.

Key points emphasized include magnesium’s primary mechanism as an NMDA receptor antagonist, its strongest evidence base for migraine prophylaxis, the importance of choosing bioavailable formulations, and the need for realistic expectations given the modest overall clinical evidence. The safety section highlights the generally favorable profile while noting important considerations for patients with renal impairment.

References

Magnesium and Pain. Shin HJ, Na HS, Do SH. Nutrients. 2020;12(8):E2184. doi:10.3390/nu12082184.
Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Park R, Ho AM, Pickering G, et al. Anesthesia and Analgesia. 2020;131(3):764-775. doi:10.1213/ANE.0000000000004673.
Magnesium for Pain Treatment in 2021? State of the Art. Morel V, Pickering ME, Goubayon J, et al. Nutrients. 2021;13(5):1397. doi:10.3390/nu13051397.
Magnesium in Pain Research: State of the Art. Srebro D, Vuckovic S, Milovanovic A, et al. Current Medicinal Chemistry. 2017;24(4):424-434. doi:10.2174/0929867323666161213101744.
Intravenous Magnesium for the Management of Chronic Pain:An Updated Review of the Literature. Onyeaka H, Adeola J, Xu R, et al. Psychopharmacology Bulletin. 2024;54(4):81-105.
Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients With Fibromyalgia: A Randomized Double-Blind Clinical Trial. Macian N, Dualé C, Voute M, et al. Nutrients. 2022;14(10):2088. doi:10.3390/nu14102088.
Clinical Efficacy of Magnesium in Perioperative Pain Management: A Narrative Review. Ahmadzadeh S, Wentling JG, Ford BM, et al. Current Pain and Headache Reports. 2025;29(1):117. doi:10.1007/s11916-025-01422-y.
Local Magnesium Sulfate Administration Ameliorates Nociception, Peripheral Inflammation, and Spinal Sensitization in a Rat Model of Incisional Pain. Wen ZH, Wu ZS, Huang SY, et al. Neuroscience. 2024;547:98-107. doi:10.1016/j.neuroscience.2024.03.033.
Magnesium Attenuates Chronic Hypersensitivity and Spinal Cord NMDA Receptor Phosphorylation in a Rat Model of Diabetic Neuropathic Pain. Rondón LJ, Privat AM, Daulhac L, et al. The Journal of Physiology. 2010;588(Pt 21):4205-15. doi:10.1113/jphysiol.2010.197004.
Management of Headache (2023). Jane Abanes PhD DNP MSN/Ed PMHCNS PMHNP-BC RN, Natasha M. Antonovich PharmD BCPS, Andrew C. Buelt DO, et al. Department of Veterans Affairs.
Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review. von Luckner A, Riederer F. Headache. 2018;58(2):199-209. doi:10.1111/head.13217.
Magnesium Disorders. Touyz RM, de Baaij JHF, Hoenderop JGJ. The New England Journal of Medicine. 2024;390(21):1998-2009. doi:10.1056/NEJMra1510603.
Nutritional Intake and Bone Health. Rizzoli R, Biver E, Brennan-Speranza TC. The Lancet. Diabetes & Endocrinology. 2021;9(9):606-621. doi:10.1016/S2213-8587(21)00119-4.
A Comparison of Marine and Non-Marine Magnesium Sources for Bioavailability and Modulation of TRPM6/TRPM7 Gene Expression in a Caco-2 Epithelial Cell Model. Demehin OA, Ryan M, Higgins T, et al. Nutrients. 2026;18(2):324. doi:10.3390/nu18020324.
Nutritional Factors Affecting Magnesium Bioavailability: A Narrative Review. Rondón LJ. Biological Trace Element Research. 2025;:10.1007/s12011-025-04739-2. doi:10.1007/s12011-025-04739-2.
Magnesium in Disease Prevention and Overall Health. Volpe SL. Advances in Nutrition (Bethesda, Md.). 2013;4(3):378S-83S. doi:10.3945/an.112.003483.
In Vitro Evaluation of Bioavailability of Mg From Daily Food Rations, Dietary Supplements and Medicinal Products From the Polish Market. Bawiec P, Jaworowska A, Sawicki J, et al. Nutrients. 2025;17(5):748. doi:10.3390/nu17050748.
Magnesium and Drugs. Gröber U. International Journal of Molecular Sciences. 2019;20(9):E2094. doi:10.3390/ijms20092094.
Magnesium Sulfate. Food and Drug Administration. Updated date: 2023-07-17.
Magnesium Sulfate in Dextrose. Food and Drug Administration. Updated date: 2026-02-11.
Drug-Induced Alterations in Mg2+ Homoeostasis. Lameris AL, Monnens LA, Bindels RJ, Hoenderop JG. Clinical Science (London, England : 1979). 2012;123(1):1-14. doi:10.1042/CS20120045.
Bioaccessibility and Bioavailability of a Marine-Derived Multimineral, Aquamin-Magnesium. Felice VD, O’Gorman DM, O’Brien NM, Hyland NP. Nutrients. 2018;10(7):E912. doi:10.3390/nu10070912.
Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPETM Microcapsules) Versus Other Magnesium Sources. Pajuelo D, Meissner JM, Negra T, Connolly A, Mullor JL. Nutrients. 2024;16(24):4367. doi:10.3390/nu16244367.
Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best?. Uysal N, Kizildag S, Yuce Z, et al. Biological Trace Element Research. 2019;187(1):128-136. doi:10.1007/s12011-018-1351-9.
Bioavailability of Magnesium and Potassium Salts Used as Potential Substitutes for Sodium Chloride in Human Nutrition – A Review. Merschmann R, Burgmer C, Eckert GP, Wagner AE. Molecular Nutrition & Food Research. 2025;:e70227. doi:10.1002/mnfr.70227.

Emphasis on Education

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

For more information, please contact Accurate Clinic.

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.